1. Combinational blockade of MET and PD-L1 improves pancreatic cancer immunotherapeutic efficacy
   Enliang Li et al, 2021, Journal of Experimental & Clinical Cancer Research CrossRef
2. Targeting HGF/c-MET Axis in Pancreatic Cancer
   Srinivasa P. Pothula et al, 2020, International Journal of Molecular Sciences CrossRef
3. Discovery of Selective Matriptase and Hepsin Serine Protease Inhibitors: Useful Chemical Tools for Cancer Cell Biology
   Vishnu C. Damalanka et al, 2019, Journal of Medicinal Chemistry CrossRef
4. Application of C. elegans cancer screening test for the detection of pancreatic tumor in genetically engineered mice
   Yuji Ueda et al, 2019, Oncotarget CrossRef
5. MET/HGF Co-Targeting in Pancreatic Cancer: A Tool to Provide Insight into the Tumor/Stroma Crosstalk
   Chiara Modica et al, 2018, International Journal of Molecular Sciences CrossRef
6. Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review
   Tomas Koltai et al, 2022, Cancers CrossRef